FollowTheFilings
Managers
Activity
Compare
Newest
Investment
PROTAGONIST THERAPEUTICS INC
Historical 13F holders
CUSIP
74366E102
Type
Equity
Class
COM
Period
13F filings
2026 Q1
7
2025 Q4
10
2025 Q3
8
2025 Q2
8
2025 Q1
8
2024 Q4
8
2024 Q3
8